Skip to main content
Premium Trial:

Request an Annual Quote

Mats Nilsson, Björn Ekström, Olle Ericsson, Ulf Landegren, Simon Fredriksson, Joe Beery, Michael Henighan, Nicholas Price

Premium
Olink Genomics, a newly formed subsidiary of Olink (see feature story, in this issue), has named Mats Nilsson, Björn Ekström, and Olle Ericsson to its board of directors, and Ulf Landegren and Simon Fredriksson to its scientific advisory board.
 
Nilsson is an associate professor and a group leader at the Rudbeck Laboratory at Uppsala University. He is the co-founder of Olink, Q-linea, and ParAllele Bioscience, now part of Affymetrix.
 
Ekström is CEO and co-founder of Olink. In the past, he held various R&D positions at Pharmacia Biotech, now part of GE Healthcare. He is also a former executive vice president, chief technology officer, and co-founder of Pyrosequencing, now Biotage. He further founded Becan, a technology and management consulting company. Ekström holds an MS in physical biochemistry from the Institute of Technology in Lund, Sweden.  
 
Ericsson is president, CEO, and a co-founder of Olink Genomics. He is also an affiliated scientist at the Rudbeck Laboratory at Uppsala University, where he recently completed his PhD.
 
Landegren is a professor at Uppsala University. He is also a scientific co-founder of Olink and ParAllele Bioscience.
 
Fredriksson is chief scientific officer and a scientific co-founder of Olink. Previously, he was staff scientist at Stanford University.
 

 
Joe Beery has become senior vice president and head of global information technology of Invitrogen.
 
Most recently, he was senior vice president and chief information officer at US Airways, and before that CIO of America West. Prior to that, he held multiple roles at Motorola Semiconductor and NV Philips.
 
According to Invitrogen, Beery “will be instrumental in integrating Invitrogen and Applied Biosystems technologies to give our customers access to an even greater breadth of products and solutions.” He holds a bachelor's degree in business administration and business computer systems from the University of New Mexico.
 

 
Michael Henighan has been appointed as chief financial officer and principal accounting officer at Alpha Innotech. In the past, he held senior management positions with Applied Biosystems, Solectron, and Motorola.
 

 
Nicholas Price has joined Zygem as US-based technical director. He comes to Zygem from Invitrogen, where he was an R&D program manager and scientist. Price holds a PhD in biology from Universidade Nova de Lisboa in Portugal, an MS in biotechnology from the University of Kent in the UK, and a BS in applied chemistry from Nottingham and Trent University, also in the UK.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.